SGH
Sivik Global Healthcare Portfolio holdings
AUM $224M
1-Year Return
5.3%
This Quarter Return
+4.61%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$183M
AUM Growth
+$2.09M
(+1.2%)
Cap. Flow
-$3.72M
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
49.86%
Holding
44
New
6
Increased
10
Reduced
9
Closed
13
Top Buys
| 1 |
Intuitive Surgical
ISRG
|
+$6.93M |
| 2 |
Medtronic
MDT
|
+$6.74M |
| 3 |
Baxter International
BAX
|
+$5.99M |
| 4 |
AstraZeneca
AZN
|
+$5.15M |
| 5 |
Gilead Sciences
GILD
|
+$4.48M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$5.24M |
| 2 |
Eli Lilly
LLY
|
+$4.96M |
| 3 |
AbbVie
ABBV
|
+$4.44M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$3.96M |
| 5 |
UnitedHealth
UNH
|
+$3.93M |
Sector Composition
| 1 | Healthcare | 88.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
SPDR S&P Biotech ETF
XBI
$5.45B
| $20.3M | 10.96% |
250,000
+50,000
| +25% | +$4.06M |
|
2
Boston Scientific
BSX
$147B
| $10.1M | 5.45% |
100,000
-10,000
| -9% | -$1.01M |
|
3
Tenet Healthcare
THC
$16.2B
| $9.42M | 5.09% |
70,000
+15,000
| +27% | +$2.02M |
|
4
HCA Healthcare
HCA
$93.6B
| $8.64M | 4.67% |
25,000
+5,000
| +25% | +$1.73M |
|
|
5
Eli Lilly
LLY
$686B
| $7.43M | 4.02% |
9,000
-6,000
| -40% | -$4.96M |
|
6
McKesson
MCK
$86.7B
| $7.4M | 4% |
11,000
-4,000
| -27% | -$2.69M |
|
7
Danaher
DHR
$137B
| $7.18M | 3.88% |
35,000
+10,000
| +40% | +$2.05M |
|
8
Cencora
COR
$56.2B
| $6.95M | 3.76% |
25,000
| – | – |
|
|
9
Intuitive Surgical
ISRG
$156B
| $6.93M | 3.75% |
+14,000
| New | +$6.93M |
|
10
Cardinal Health
CAH
$35.7B
| $6.89M | 3.72% |
50,000
| – | – |
|
|
11
Medtronic
MDT
$121B
| $6.74M | 3.64% |
+75,000
| New | +$6.74M |
|
12
Stryker
SYK
$144B
| $6.51M | 3.52% |
17,500
-2,500
| -13% | -$931K |
|
13
Waters Corp
WAT
$18B
| $6.27M | 3.39% |
17,000
+3,000
| +21% | +$1.11M |
|
14
Universal Health Services
UHS
$11.9B
| $6.11M | 3.3% |
32,500
-5,000
| -13% | -$940K |
|
15
Humana
HUM
$32.6B
| $6.09M | 3.29% |
23,000
+3,000
| +15% | +$794K |
|
|
16
Baxter International
BAX
$12.3B
| $5.99M | 3.24% |
+175,000
| New | +$5.99M |
|
17
Abbott
ABT
$231B
| $5.97M | 3.23% |
45,000
-5,000
| -10% | -$663K |
|
18
Agilent Technologies
A
$36B
| $5.85M | 3.16% |
50,000
+15,000
| +43% | +$1.75M |
|
19
Encompass Health
EHC
$12.5B
| $5.23M | 2.83% |
51,600
+6,600
| +15% | +$668K |
|
|
20
AstraZeneca
AZN
$241B
| $5.15M | 2.78% |
+70,000
| New | +$5.15M |
|
21
Novo Nordisk
NVO
$254B
| $4.86M | 2.63% |
70,000
| – | – |
|
|
22
Gilead Sciences
GILD
$138B
| $4.48M | 2.42% |
+40,000
| New | +$4.48M |
|
23
Cigna
CI
$78.6B
| $4.11M | 2.22% |
12,500
+500
| +4% | +$165K |
|
24
Smith & Nephew
SNN
$16.3B
| $3.4M | 1.84% |
120,000
-5,000
| -4% | -$142K |
|
25
Select Medical
SEM
$1.51B
| $3.34M | 1.81% |
200,000
+50,000
| +33% | +$835K |
|